Hypertrophy, Left Ventricular clinical trials
The registry lists 119 studies for Hypertrophy, Left Ventricular across more than 10 countries. 23 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-10.
Status
- Completed
- 65
- Recruiting
- 18
- Status unknown
- 17
- Terminated
- 8
- Not yet recruiting
- 4
- Active, not recruiting
- 3
Phase
- Phase 4
- 24
- Phase 3
- 15
- Phase 2
- 11
- Early Phase 1
- 1
Where
- United States
- 30
- United Kingdom
- 15
- Germany
- 11
- Italy
- 9
- Austria
- 6
- France
- 6
Who runs them
University of Dundee (4) · National Heart, Lung, and Blood Institute (NHLBI) (4) · Assiut University (3) · University of Aarhus (3) · Unity Health Toronto (3) · Medical University of Vienna (3) · Massachusetts General Hospital (3) · Novartis (2)
Studies
Recruiting first, then most recently updated. Showing 50 of 119 — search for more.
- Study of LX2006 Gene Therapy in Friedreich Ataxia CardiomyopathyRecruitingNCT07721025Phase 21 country
- Detection of Cardiac Amyloidosis Using Right Ventricular Sensing Amplitude in Patients With Left Ventricular HypertrophyNot yet recruitingNCT07734285Not applicable
- Angiotensin Receptor Blocker After TAVR in Severe Aortic Stenosis With Left Ventricular Hypertrophy (ARBITAR)Not yet recruitingNCT07735130Phase 41 country
- AI-based Echocardiography for Detection of Cardiac AmyloidosisNot yet recruitingNCT07529860Not applicable
- A Gene Therapy Study of RP-A501 in Male Patients With Danon DiseaseRecruitingNCT06092034Phase 24 countries
- Triple Combination Therapy (ARNI, SGLT2i, MRA) in Advanced HFpEFRecruitingNCT06655480Phase 21 country
- Predictors of Poor Prognosis in HFpEFRecruitingNCT068440321 country
- Mineralocorticoid Receptor, Coronary Microvascular Function, and Cardiac Efficiency in HypertensionRecruitingNCT05593055Phase 41 country
- Left Ventricular Hypertrophy in CKD PatientsNot yet recruitingNCT07380893
- Evaluation of Left Ventricular Ejection Fraction Using an Accelerated Cardiac Cine-MRI Sequence With Deep Learning-based Image ReconstructionsRecruitingNCT07061821Not applicable1 country
- Diffusion MRI in Heart FailureRecruitingNCT02973633Early Phase 11 country
- Imaging Histone Deacetylase in the HeartRecruitingNCT03549559Not applicable1 country
- Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)RecruitingNCT047522931 country
- Austrian Hypertrophic Cardiomyopathy RegistryRecruitingNCT063685181 country
- AI-Enabled Diagnosis and Prognosis of Hypertrophic CardiomyopathyRecruitingNCT072632041 country
- US Benchmarking Clinical StudyRecruitingNCT072157151 country
- Postnatal Steroids Effects on Cardiac Function in Extremely PretermRecruitingNCT046440941 country
- Sodium Lowering Vascular Effects TrialRecruitingNCT05388032Not applicable1 country
- A Study to Evaluate Accuracy and Validity of the Chang Gung ECG Abnormality Detection SoftwareEnrolling by invitationNCT059033131 country
- Screening Patients With Fabry Disease in Patients With Hypertrophic Cardiomyopathy or Left Ventricular HypertrophyRecruitingNCT061693581 country
- Response of the Myocardium to Hypertrophic Conditions in the Adult PopulationRecruitingNCT026700311 country
- Etiological DiagnOsis of caRdiac Diseases Based on echoCardiograpHIc Images and Clinical Data.RecruitingNCT059427291 country
- Multi-Modality Echocardiographic Techniques in Pathological Left Ventricular Hypertrophy AdultsRecruitingNCT057193371 country
- Early Valve Replacement Guided by Biomarkers of LV Decompensation in Asymptomatic Patients With Severe ASActive, not recruitingNCT03094143Not applicable1 country
- Point-of-care Ultrasound and Treatment Disparities for Left Ventricular HypertrophyCompletedNCT05730309Not applicable1 country
- CMR T1 Mapping for Diagnosis of Cardiac AmyloidosisCompletedNCT048622731 country
- SGLT2 Inhibition in HemodialysisCompletedNCT05179668Phase 21 country
- ReNEW Clinic Cohort StudyCompletedNCT038164621 country
- Towards Understanding the Phenotype of Cardiovascular Disease in CKD - TRUE-Type-CKD StudyCompletedNCT037495511 country
- The COlchicine HypERtENsion TrialActive, not recruitingNCT04916522Phase 21 country
- Assessment of Efficacy of Mirabegron, a New beta3-adrenergic Receptor in the Prevention of Heart FailureCompletedNCT02599480Phase 28 countries
- Effect of a Targeted Notification and Clinical Support Pathway on Individuals With Left Ventricular HypertrophyCompletedNCT05713916Not applicable1 country
- A Noninterventional, Single-Center Feasibility Study to Evaluate Measures of Heart Failure RiskCompletedNCT056460561 country
- Screening of Fabry Disease in Patients With Left Ventricular Hypertrophy Detected in EchocardiographyCompletedNCT022211411 country
- Fabry Disease in High-risk Patients With Left Ventricular Hypertrophy: Prevalence and Implementation of a Clinical ScoreActive, not recruitingNCT04943991Not applicable1 country
- Mechanism of Decompensation Evaluation - Aortic StenosisCompletedNCT033327451 country
- Prevalence and Characteristics of Transthyretin Amyloidosis in Patients With Left Ventricular Hypertrophy of Unknown EtiologyCompletedNCT0384216310 countries
- Access Creation for Hemodialysis: Association With Structural Changes of the HeartCompletedNCT003681471 country
- Sacubitril/Valsartan Versus Amlodipine in Hypertension and Left Ventricular Hypertrophy.Status unknownNCT04929600Phase 41 country
- Efficacy of Angiotensin Receptor Blocker Following aortIc Valve Intervention for Aortic STenOsis: a Randomized mulTi-cEntric Double-blind Phase II StudyWithdrawnNCT03315832Phase 2/31 country
- Empagliflozin and Cardiac Remodelling in People Without DiabetesCompletedNCT04461041Phase 42 countries
- The Use of Blood Biochemical Markers for Diagnostics of Heart Muscle DiseasesStatus unknownNCT057266951 country
- Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV DiseaseCompletedNCT03666351Phase 41 country
- FGF23 and Angiotensin-(1-7) in Hypophosphatemia (GAP)CompletedNCT034899931 country
- Stress Reduction in the Prevention of Left Ventricular HypertrophyCompletedNCT05373732Not applicable
- Demographical and Clinical Profile of Patients With Left Ventricular HypertrophyCompletedNCT042758821 country
- Left Ventricular Hypertrophy Among Chronic Kidney Disease Patients in Assiut University HospitalStatus unknownNCT05002010
- Effect of Dapagliflozin on Myocardial and Renal Function Following Aortic Valve Stenosis InterventionStatus unknownNCT05241431Phase 2/31 country
- Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study (0954-133)CompletedNCT00338260Phase 3
- Predictors of Left Ventricular Hypertrophy in Hypertensive Patients in Assiut GovernorateCompletedNCT034829341 country